Posts Tagged ‘monday

This entry was posted on Monday, March 8th, 2010 at 7:16 pm and is filed under Biotechnology .

08 March 2010.

Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.

Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.

Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.

Shares of drug developer Anthera Pharmaceuticals are climbing in their market debut Monday.

Biodel Inc.

Japanese drugmaker Astellas Pharma Inc. said Monday it will take a $3.5 billion takeover offer for OSI Pharmaceuticals directly to shareholders after being rebuffed several times by executives of the U.S

German pharmaceutical giant Merck KGaA on Monday hailed its takeover of Millipore, a US biotechnology firm, with Merck chief executive Karl-Ludwig Kley saying he felt as though he had won a gold medal.

In the biotechnology business, where executives or even entire companies can come and go in an instant, Henri A. Termeer has been a constant.


About Biolexis

Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.

Biotech

    Ground breaking event 3Groundbreaking eventGroundbreaking event 2Janice with Max ArmstrongKaisan MahadiKaisan Mahadi